Martingale Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25M | Sell |
179,462
-14,459
| -7% | -$2.02M | 0.63% | 47 |
|
|
2025
Q4 | $23.8M | Buy |
193,921
+21,153
| +12% | +$2.57M | 0.61% | 48 |
|
|
2025
Q3 | $19.2M | Sell |
172,768
-21,469
| -11% | -$2.44M | 0.48% | 72 |
|
|
2025
Q2 | $21.5M | Sell |
194,237
-2,441
| -1% | -$260K | 0.53% | 70 |
|
|
2025
Q1 | $22M | Sell |
196,678
-32,824
| -14% | -$3.39M | 0.56% | 60 |
|
|
2024
Q4 | $21.2M | Sell |
229,502
-26,008
| -10% | -$2.34M | 0.52% | 69 |
|
|
2024
Q3 | $21.4M | Sell |
255,510
-48,012
| -16% | -$3.66M | 0.49% | 79 |
|
|
2024
Q2 | $20.8M | Sell |
303,522
-11,369
| -4% | -$759K | 0.45% | 86 |
|
|
2024
Q1 | $23.1M | Sell |
314,891
-23,136
| -7% | -$1.78M | 0.46% | 85 |
|
|
2023
Q4 | $27.4M | Sell |
338,027
-24,502
| -7% | -$1.91M | 0.56% | 69 |
|
|
2023
Q3 | $27.2M | Sell |
362,529
-16,964
| -4% | -$1.3M | 0.57% | 64 |
|
|
2023
Q2 | $29.2M | Sell |
379,493
-17,267
| -4% | -$1.38M | 0.57% | 62 |
|
|
2023
Q1 | $32.9M | Buy |
396,760
+432
| +0.1% | +$35.8K | 0.63% | 50 |
|
|
2022
Q4 | $34M | Sell |
396,328
-37,797
| -9% | -$2.99M | 0.66% | 49 |
|
|
2022
Q3 | $26.8M | Sell |
434,125
-622
| -0.1% | -$39.2K | 0.53% | 70 |
|
|
2022
Q2 | $26.9M | Sell |
434,747
-19,621
| -4% | -$1.21M | 0.49% | 75 |
|
|
2022
Q1 | $27M | Buy |
454,368
+198,546
| +78% | +$12.7M | 0.41% | 98 |
|
|
2021
Q4 | $18.6M | Buy |
255,822
+238,667
| +1,391% | +$16.4M | 0.24% | 135 |
|
|
2021
Q3 | $1.2M | Buy |
+17,155
| New | +$1.21M | 0.02% | 469 |
|
|
2020
Q1 | – | Sell |
-6,035
| Closed | -$393K | – | 985 |
|
|
2019
Q4 | $393K | Sell |
6,035
-20,105
| -77% | -$1.31M | ﹤0.01% | 900 |
|
|
2019
Q3 | $1.66M | Sell |
26,140
-5,292
| -17% | -$346K | 0.02% | 640 |
|
|
2019
Q2 | $2.12M | Sell |
31,432
-22,895
| -42% | -$1.51M | 0.02% | 577 |
|
|
2019
Q1 | $3.53M | Buy |
54,327
+896
| +2% | +$59.6K | 0.04% | 464 |
|
|
2018
Q4 | $3.34M | Buy |
53,431
+4
| +0% | +$280 | 0.04% | 421 |
|
|
2018
Q3 | $4.13M | Sell |
53,427
-8,494
| -14% | -$641K | 0.05% | 366 |
|
|
2018
Q2 | $4.39M | Buy |
61,921
+3,393
| +6% | +$240K | 0.05% | 350 |
|
|
2018
Q1 | $4.41M | Sell |
58,528
-390
| -0.7% | -$31K | 0.06% | 329 |
|
|
2017
Q4 | $4.22M | Sell |
58,918
-2,693
| -4% | -$205K | 0.06% | 334 |
|
|
2017
Q3 | $4.99M | Sell |
61,611
-697
| -1% | -$53.3K | 0.07% | 306 |
|
|
2017
Q2 | $4.41M | Sell |
62,308
-8,887
| -12% | -$591K | 0.06% | 321 |
|
|
2017
Q1 | $4.84M | Sell |
71,195
-63,846
| -47% | -$4.49M | 0.07% | 301 |
|
|
2016
Q4 | $9.67M | Sell |
135,041
-8,674
| -6% | -$645K | 0.14% | 187 |
|
|
2016
Q3 | $11.4M | Sell |
143,715
-850
| -0.6% | -$69K | 0.17% | 167 |
|
|
2016
Q2 | $12.1M | Buy |
144,565
+648
| +0.5% | +$57.5K | 0.2% | 157 |
|
|
2016
Q1 | $13.2M | Buy |
143,917
+1,762
| +1% | +$159K | 0.26% | 137 |
|
|
2015
Q4 | $14.4M | Buy |
142,155
+2,398
| +2% | +$250K | 0.32% | 108 |
|
|
2015
Q3 | $13.7M | Sell |
139,757
-2,250
| -2% | -$250K | 0.34% | 96 |
|
|
2015
Q2 | $16.6M | Sell |
142,007
-4,099
| -3% | -$448K | 0.39% | 73 |
|
|
2015
Q1 | $14.3M | Buy |
146,106
+9,001
| +7% | +$914K | 0.34% | 86 |
|
|
2014
Q4 | $12.9M | Sell |
137,105
-9,494
| -6% | -$982K | 0.36% | 74 |
|
|
2014
Q3 | $15.6M | Buy |
146,599
+683
| +0.5% | +$66.9K | 0.49% | 41 |
|
|
2014
Q2 | $12.1M | Buy |
145,916
+2,013
| +1% | +$157K | 0.38% | 61 |
|
|
2014
Q1 | $10.2M | Sell |
143,903
-3,426
| -2% | -$269K | 0.35% | 75 |
|
|
2013
Q4 | $11.1M | Sell |
147,329
-28,848
| -16% | -$2.01M | 0.38% | 47 |
|
|
2013
Q3 | $11.1M | Sell |
176,177
-16,777
| -9% | -$1M | 0.39% | 51 |
|
|
2013
Q2 | $9.89M | Buy |
+192,954
| New | +$10.1M | 0.37% | 56 |
|
Other funds holding GILD
VCM
VPM
Martingale Asset Management's GILD Position: Q1 2026 in Review
Martingale Asset Management reduced its Gilead Sciences (GILD) stake by 7.5% in Q1 2026, selling an estimated $2.02M and leaving 179,462 shares worth $25M. The position accounts for 0.63% of the portfolio, ranked #47.
Martingale Asset Management first reported a position in GILD in Q2 2013 and has held it in 46 quarters since. The position peaked at $34M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Martingale Asset Management held 179,462 shares of Gilead Sciences worth $25M as of Q1 2026.
- Martingale Asset Management sold 14,459 Gilead Sciences shares in Q1 2026, an estimated $2.02M.
- Gilead Sciences made up 0.63% of Martingale Asset Management's portfolio in Q1 2026, its #47 holding.
- Martingale Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 46 quarters since.
- Martingale Asset Management's Gilead Sciences position peaked at $34M in Q4 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.